{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T22:08:41Z","timestamp":1726438121948},"reference-count":25,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":5319,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1994,10]]},"abstract":"<jats:p>Polycythemia vera (PV) is a chronic myeloproliferative disease. The use of recombinant \u03b12a Interferon (IFN) therapy in this disease is a novel approach. We applied Fourier\u2010transform infrared microspectroscopy (FT\u2010IR\u2010M) to investigate the behavior and therapeutic responsiveness of PV patients treated with IFN. A spectroscopic parameter (A<jats:sub>1<\/jats:sub>\/A<jats:sub>2<\/jats:sub>) was used, corresponding to the ratio of the integrated areas of the bands at 1080 cm<jats:sup>\u20101<\/jats:sup> and at 1540 cm<jats:sup>\u20101<\/jats:sup> due to nucleic acids and proteic components, respectively, calculated on the spectra of single megakaryocytes (MKs). In previous studies, we have pointed out that MKs in PV have a surprisingly strong myeloproliferative impulse when compared to MKs from other chronic myeloproliferative diseases. Nine patients out of the 11 studied exhibited a satisfactory responsiveness to the IFN treatment. Ten patients were evaluated by the A<jats:sub>1<\/jats:sub>\/A<jats:sub>2<\/jats:sub> parameter. In 8 of these, a good agreement was seen between this parameter and the laboratory data commonly used for the assessment of this disease. The infrared parameter, which we propose, proves to be an original, reliable method for the evaluation of recombinant \u03b12a IFN responsiveness in this disease.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1994.tb00191.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T02:24:24Z","timestamp":1279419864000},"page":"213-217","source":"Crossref","is-referenced-by-count":15,"title":["Recombinant \u03b12a interferon and polycythemia vera: Clinical results and biological evaluation by means of Fourier\u2010transform infrared microspectroscopy"],"prefix":"10.1111","volume":"53","author":[{"given":"F.","family":"Papineschi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bucalossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Capochiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Bramanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Dastoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Dispensa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Spremolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-95-1-71"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197610212951702"},{"key":"e_1_2_1_4_2","first-page":"220","article-title":"Treatment of Polycythemia Vera","author":"Gardner FH.","year":"1966","journal-title":"Semin Hematol"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1182\/blood.V36.1.70.70","article-title":"Melphalan therapy of Polycythemia Vera","volume":"36","author":"Logue GL","year":"1980","journal-title":"Blood"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19860215)57:4<718::AID-CNCR2820570406>3.0.CO;2-P"},{"key":"e_1_2_1_7_2","first-page":"499","article-title":"Polycythemia Vera: clinical studies on a series of 127 patients managed without radiation therapy","volume":"33","author":"Perkins J.","year":"1964","journal-title":"Q J Med"},{"key":"e_1_2_1_8_2","first-page":"30","article-title":"Influence of therapy on causes of death in Polycythemia Vera","author":"Wassweman LR","year":"1981","journal-title":"Trans Assoc Am Phisicians"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830340108"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1182\/blood.V69.5.1280.1280","article-title":"Clinical investigation of human Alpha\u2010Interferon in chronic myelogenous leukaemia","volume":"69","author":"Talpaz M.","year":"1987","journal-title":"Blood"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01703444"},{"issue":"45","key":"e_1_2_1_12_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0609.1990.tb00899.x","article-title":"Therapy of essential thrombocythemia with alpha\u2010Interferon: results and prospects","author":"Lazzarino M.","year":"1990","journal-title":"Eur J Haematol"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V76.4.664.664","article-title":"A new treatment for Polycythemia Vera. Recombinant interferon alpha","volume":"76","author":"Silver RT.","year":"1990","journal-title":"Blood"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1182\/blood.V77.12.2790.2790","article-title":"Recombinant interferon a in the treatment of Polycythemia Vera","volume":"77","author":"Cacciola E.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_1_15_2","first-page":"663","article-title":"Resistant Polycythemia Vera. Successful therapy with non recombinant or recombinant alpha interferon","volume":"77","author":"Giles FJ","year":"1991","journal-title":"Br J Hamatol"},{"key":"e_1_2_1_16_2","first-page":"75","article-title":"Interferon in Polycythemia Vera and essential thrombocythemia","volume":"76","author":"Turri D.","year":"1991","journal-title":"Haema-tologica"},{"key":"e_1_2_1_17_2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1182\/blood.V63.3.615.615","article-title":"Characterization in myeloproliferative disorders","volume":"63","author":"Rabellino EM","year":"1984","journal-title":"Blood"},{"key":"e_1_2_1_18_2","unstructured":"RakK. KissA. TelekB.Pure or dominant megakaryo\u2010blastic transformation in chronic myeloproliferative disorders. Proc 24th Congress of the International Society on haematology South Bank Centre London August 23\u2013271992 1338 A."},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(85)90070-0"},{"key":"e_1_2_1_20_2","first-page":"139","article-title":"FT\u2010IR analysis of single human normal and leukemic lymphocytes","volume":"1","author":"Benedetti E.","year":"1998","journal-title":"Mi-crochimica Acta"},{"key":"e_1_2_1_21_2","first-page":"573","article-title":"Microspettroscopia FT\u2010IR: Una nuova metodica nella caratterizzazione delle cellule leucemiche","volume":"5","author":"Spremolla G.","year":"1989","journal-title":"Haematologica"},{"key":"e_1_2_1_22_2","first-page":"307","article-title":"A new approach to the characterization of megakaryocytes from myeloproliferative disorders by means of FT \u2014 IR Microspectroscopy","volume":"76","author":"Papineschi F.","year":"1990","journal-title":"Blood"},{"key":"e_1_2_1_23_2","unstructured":"PapineschiF. BucalossiA. CapochianiE. et al.Recombinant Interferon\u2010alpha 2a for treatment of Polycythemia Vera: Fourier transform infrared microspectroscopy (FT\u2010IR) study. Proc 24th Congress of the International Society of Haematology South Bank Centre London August 2327 1992 1345A."},{"key":"e_1_2_1_24_2","unstructured":"PapineschiF. BenedettiE.jr CapochianiE. VergaminiP. BenedettiE. SpremollaG.Fourier\u2010Transform Infrared Microspectroscopy (FT\u2010IR) studies on chronic myeloid leukaemia megakaryocytes. Proc 2nd International Conference: Chronic Myeloid Leukemia Bologna 4\u20137 October1992 125A."},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110962"},{"key":"e_1_2_1_26_2","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1182\/blood.V61.5.876.876","article-title":"Individual BFU\u2010E in Polycythemia Vera Produce Both Erythropoietin Dependent and Independent Progeny","volume":"61","author":"Cashman J.","year":"1983","journal-title":"Blood"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1994.tb00191.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1994.tb00191.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T06:19:04Z","timestamp":1698128344000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1994.tb00191.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,10]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1994,10]]}},"alternative-id":["10.1111\/j.1600-0609.1994.tb00191.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1994.tb00191.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"type":"print","value":"0902-4441"},{"type":"electronic","value":"1600-0609"}],"subject":[],"published":{"date-parts":[[1994,10]]}}}